Brief: Japan Tobacco Top-Line Results Of Phase 3 Clinical Studies Of JTZ-951 In Anemic Patients With Chronic Kidney Disease In Japan

Torii Pharmaceutical Co

12/07/2019 07:13

July 12 (Reuters) - Japan Tobacco Inc  2914.T :
    * TOP-LINE RESULTS OF PHASE 3 CLINICAL STUDIES OF JTZ-951 IN
ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE IN JAPAN
    * RESULTS SHOW BOTH STUDIES MET PRIMARY ENDPOINTS
    * JT AND TORII  4551.T  WILL AIM TO SUBMIT MARKETING
APPLICATION
FOR JTZ-951 IN JAPAN BASED ON RESULTS OF THIS AND OTHER CLINICAL
STUDIES

Source text for Eikon:  ID:nTSSL72d36 
Further company coverage:  2914.T 

 (Reporting By Chris Gallagher)
 ((chris.gallagher@thomsonreuters.com;))